James Treace - Nov 15, 2021 Form 4 Insider Report for TREACE MEDICAL CONCEPTS, INC. (TMCI)

Role
Director
Signature
/s/ Lisa Taylor as Attorney-in-fact for James T. Treace
Stock symbol
TMCI
Transactions as of
Nov 15, 2021
Transactions value $
-$1,545,515
Form type
4
Date filed
11/17/2021, 07:32 PM
Next filing
Nov 24, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TMCI Common Stock Sale -$398K -19.5K -0.88% $20.41 2.19M Nov 15, 2021 Direct F1, F2
transaction TMCI Common Stock Sale -$118K -5.52K -0.25% $21.41 2.18M Nov 15, 2021 Direct F1, F3
transaction TMCI Common Stock Sale -$522K -25K -1.15% $20.86 2.16M Nov 16, 2021 Direct F1, F4
transaction TMCI Common Stock Sale -$508K -25K -1.16% $20.33 2.13M Nov 17, 2021 Direct F1, F5
transaction TMCI Common Stock Gift $0 -200K -9.39% $0.00 1.93M Oct 27, 2021 Direct F6
transaction TMCI Common Stock Gift $0 -200K -10.36% $0.00 1.73M Oct 27, 2021 Direct F7
transaction TMCI Common Stock Gift $0 -600K -34.68% $0.00 1.13M Nov 12, 2021 Direct F8
holding TMCI Common Stock 600K Nov 15, 2021 By spouse
holding TMCI Common Stock 1.48M Nov 15, 2021 J&A Group, LLC F9
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.
F2 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $19.98 to $20.95 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $20.99 to $21.87 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $20.46 to $21.18 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F5 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.87 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F6 Gift transfer to a natural person.
F7 Gift transfer to a second natural person.
F8 Gift transfer to reporting person's spouse.
F9 James T. Treace and his spouse are managing members of J&A Group, LLC, a Florida limited liability company.